Talk:CDK inhibitor
Appearance
This article is rated Start-class on Wikipedia's content assessment scale. It is of interest to the following WikiProjects: | ||||||||||||||
|
Clinical trials
[edit]As of Dec 2012[update] CDK inhibitor trials lists 47 trials, many completed. - Rod57 (talk) 13:43, 10 December 2012 (UTC)
Content elsewhere could move here
[edit]Overlapping content at Cyclin-dependent_kinase#Medical_significance. Propose that most of it is merged into this article with a summary left there. - Rod57 (talk) 23:33, 10 February 2017 (UTC)
- eg. the table at Cyclin-dependent_kinase#As_drug_targets. - Rod57 (talk) 11:35, 23 September 2021 (UTC)
Things to add
[edit]- Why are the first three approved all inhibitors of both CDK4 and CDK6. (Are they close structurally ? Do they have the same binding sites ?) - Rod57 (talk) 12:00, 16 October 2017 (UTC)
Trilaciclib is now an FDA approved drug
[edit]This section needs to be updated. 64.184.156.97 (talk) 08:03, 23 April 2023 (UTC)
- Source? Agletarang (talk) 08:07, 23 April 2023 (UTC)